Complete Biochemical Response (Prostate Specific Antigen) to Sipuleucel-T in Metastatic Castrate-Resistant Prostate Cancer: A Case Report With Docetaxel Chemotherapy Administered Just Before Sipuleucel-T.
Division of Medical Oncology, Duke University Medical Center, Durham, NC. Electronic address: Megan.diehl@duke.edu.
Megan
M
McNamara
Division of Medical Oncology, Duke University Medical Center, Durham, NC.
William
W
Berry
D000368:Aged; D000077143:Docetaxel; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D017430:Prostate-Specific Antigen / Q000378:metabolism*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000378:metabolism; D043823:Taxoids / Q000008:administration & dosage* / Q000627:therapeutic use; D014020:Tissue Extracts / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome
D043823:Taxoids; D014020:Tissue Extracts; D000077143:Docetaxel; C511774:sipuleucel-T; D017430:Prostate-Specific Antigen
Immunotherapy; Order; Radiographic; Sequence; Undetectable